Baidu
map

法国医生成功为患者实施3D打印气管支气管假体植入手术

2017-03-02 佚名 分析测试百科网

近日,来自法国图卢兹CHU医院的一组医生已经成功地将3D打印?的定制气管支气管假体植入患者体内,为医学界树立了世界第一。



近日,来自法国图卢兹CHU医院的一组医生已经成功地将3D打印的定制气管支气管假体植入患者体内,为医学界树立了世界第一。据悉,该植入物是与Anatomik Modeling(一家位于图卢兹的创业公司)一起合作设计和制造的,该公司专门制作定制3D植入物。

据悉,接受定制3D植入物的是一名60岁的患者,其于两年前首先在图卢兹大学医院接受肺移植手术。然而,在手术后,患者感觉呼吸不适和呼吸困难。在检查时,医生发现患者的支气管变窄和收缩(称为狭窄病症),这对意思来说必须采取措施治疗。

医生采取的干预是以在3D打印的帮助下制造定制的硅胶气管支气管假体的形式。为了制作植入物,Anatomik Modeling与CHU合作,根据扫描的患者支气管数据对植入物进行建模。然后,3D植入物的模具被3D打印,其允许铸造硅氧烷弹性体假体。

大约三个月前,CHU的医生成功地将定制的气管支气管假体植入患者体内。术后,患者恢复良好,而且该技术已经成功帮助了三个以上的患者,并且将很快帮助目前正等待接受手术的两个患者。

3D打印技术允许法国医生使用定制的支气管植入物治疗患者,这有助于避免由于不合适的植入物和支架而导致的潜在并发症。虽然创新的3D植入物仍在实验阶段,但他们准备在2018年将其商业化。“Anatomik Modeling和CHU的医生说。

目前,3D打印的定制支架面临的挑战是它们的成本,因为定制的适合的植入物比它们的标准化对应物昂贵。尽管如此,3D气管支气管假体的临床试验仍在进行中。

关于定制的3D气管支气管假体的研究已于最近发表在美国呼吸和危重病医学杂志上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
    2017-09-09 心欲无痕 无欲则刚

    是否所有的组织都能打印

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
    2017-03-04 智智灵药
  5. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
    2017-03-04 neurowu
  6. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1892070, encodeId=ca3d18920e003, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Tue Dec 19 12:03:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2070731, encodeId=70b820e073163, content=<a href='/topic/show?id=a787626e788' target=_blank style='color:#2F92EE;'>#植入手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62677, encryptionId=a787626e788, topicName=植入手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Mar 12 10:03:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242222, encodeId=824a24222259, content=是否所有的组织都能打印, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/23/e8940e6c852aed5b3336028f3dd5ff43.jpg, createdBy=f15f2091876, createdName=心欲无痕 无欲则刚, createdTime=Sat Sep 09 17:03:41 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335945, encodeId=891c133594535, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399868, encodeId=2ee613998683a, content=<a href='/topic/show?id=51b56481e5c' target=_blank style='color:#2F92EE;'>#法国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64817, encryptionId=51b56481e5c, topicName=法国)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJAEDER5XgbF1YHYrZAUzQRb28zMfZSQYO9TlxMY9GrSlIvElouBEHntsqmbAWtxHwdqqtGx0dCsw/0, createdBy=ed132239308, createdName=neurowu, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468317, encodeId=630f146831eba, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520343, encodeId=33f315203430b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Sat Mar 04 01:03:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
    2017-03-04 jiyangfei

相关资讯

汇总!聚焦3D打印全新技术,开辟个性化医疗

从上世纪90年代开始到现在的30年里,3D打印从开始运用于汽车和航天等制造业,到近几年应用于医疗行业,打印出组织器官,并且协助完成手术,3D打印可谓改变了生产观念。在医疗行业,3D打印人造肝脏组织、3D打印人造耳、3D打印牙冠等出现在人们的视野里,3D打印为器官移植提供了多一种可能,给医疗行业带来了新的希望。本文中梅斯医学小编就3D打印的现状及进展做以整理,与大家分享交流。【1】ACS Bio

2017(第三届)医用3D打印行业峰会

自从3D打印技术成功运用在医疗领域上之后,这一高新技术就被寄予了厚望。随着社会人口老龄化的加剧和各类疾病的出现,传统的医疗手段已经不能及时满足病患的需求。

2.796亿美元!3D打印医疗器械前景可期

随着3D打印医疗器械行业的应用越来越广泛!最新数据显示,全球3D打印医疗器械市场2016年预计达到2.796亿美元,并在未来10年复合年增长率(CAGR)达到17.5%,3D打印在定制化植入物上很有优势。

ACS Biomaterials:浙大贺永教授成功进行跨尺度血管结构的生物3D打印

心血管疾病是当今世界威胁人类最严重的疾病之一,其作用机制复杂,目前基于动物实验及平面细胞实验的研究与人体环境相差甚远,如果能够在体外构建一个可以模拟体内血管环境的血管模型,在这个模型上进行化学刺激和力学刺激,将会为心血管疾病机理的探讨提供高效的工具。我们团队经过两年多的研究探索,提出了一种血管3D打印工艺,该工艺能实现宏微跨尺度血管结构的打印,宏观流道可用于各种机械力的加载,微观通道可用于营养输送

用3D打印件和智能手机DIY一个活细胞成像设备

近日,瑞典乌普萨拉大学的研究人员发明了一种成本低廉、易于组装的活细胞成像设备。该设备由一部智能手机、几个3D打印部件、一些现成的电子器件和一台标准的倒置显微镜组成。“我们的目标是让发展中国家的实验室拥有细胞实时成像技术,这个项目告诉大家3D打印将如何改变世界各地的科学家的工作方式。在资金有限的情况下,3D打印为研究人员使用曾经非常昂贵的研究方法提供了可能性,”乌普萨拉大学医学细胞生物学系的高级讲师

宇航员本月将开始在ISS上3D打印医疗用品

太空中的3D打印应用已经取得了许多突破。例如,ISS上的3D打印机已经在为宇航员制造有用的工具,并且很快有可能制造出替换部件;卫星和探索设备也正在被3D打印;目前的研究正在探索如何利用该技术帮助建设太空居住地和殖民地。然而,到目前为止,很重要的一个应用还未被提及。 多伦多的医疗3D打印公司3D4MD提出了一个创新性计划,那就是让宇航员在太空中3D打印夹板、手术工具等医疗用品,而不是坐

Baidu
map
Baidu
map
Baidu
map